CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,574 | $132.45 | $208K | 124,485 |
| 2025-08-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,326 | $133.31 | $177K | 123,159 |
| 2025-08-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −100 | $134.08 | $13K | 123,059 |
| 2025-07-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −567 | $136.01 | $77K | 67,908 |
| 2025-07-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,200 | $137.42 | $165K | 66,708 |
| 2025-07-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,278 | $138.01 | $176K | 65,430 |
| 2025-07-28 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −6,092 | $139.81 | $852K | 169,400 |
| 2025-07-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,019 | $139.81 | $282K | 68,475 |
| 2025-07-28 | Sheena Jonathan Director | Sale 10b5-1 | −479 | $139.81 | $67K | 245,322 |
| 2025-07-28 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −1,718 | $139.81 | $240K | 2,360,852 |
| 2025-07-28 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −2,206 | $139.81 | $308K | 126,059 |
| 2025-07-28 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −1,710 | $139.81 | $239K | 151,750 |
| 2025-07-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,994 | $139.81 | $279K | 202,164 |
| 2025-07-25 | Chapman Rowan E Director | Grant or award | +149 | 8,765 | ||
| 2025-07-25 | Williams Brinkley Ruth Director | Grant or award | +112 | 5,219 | ||
| 2025-07-25 | ROSENMAN HERM Director | Grant or award | +153 | 68,629 | ||
| 2025-07-25 | Marcus Gail Boxer Director | Grant or award | +141 | 8,259 | ||
| 2025-07-25 | BOTHA ROELOF Director | Grant or award | +173 | 6,690 | ||
| 2025-07-25 | Bertagnolli Monica Director | Grant or award | +108 | 5,128 | ||
| 2025-07-25 | Baynes Roy D. Director | Grant or award | +108 | 18,266 |
Page 41 of 55 · 1,093 trades